semaglutide afib Atrial Fibrillation and Effects in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Program Ozempic with AFib: Safety, Heart
Description
Participants had lost an average of 17.3 per cent of their body weight during 68 weeks of treatment
What is the most important action
In patients with T2DM, the reduction in HbA1c is not overtly different between twice daily or once daily administration of lixisenatide [892]
Versus GLP-1 receptor agonists: Tirzepatide has demonstrated superior HbA1c reduction and weight loss compared to semaglutide 1 mg in the SURPASS-2 trial
Our team of doctors is committed to delivering the highest standard of care, ensuring that your journey to weight loss is informed, effective, and tailored to your individual needs
